Inventor · disambiguated record
Elisia Villemure
Also filed as: VILLEMURE ELISIA
16 granted patents·3 pending applications·12 citations·filing 2013–2024
87Inventor score
Top patents by PatentIndex Score
19 records- 0188US12006331B2Therapeutic compounds and methodsGENENTECH INC·Filed 2022·Granted Jun 11, 2024·1 cites·17 claims
- 0287US10710994B2Oxadiazole transient receptor potential channel inhibitorsGENENTECH INC·Filed 2019·Granted Jul 14, 2020·3 cites·38 claims
- 0384US10179782B2Substituted sulfonamide compoundsGENENTECH INC·Filed 2016·Granted Jan 15, 2019·5 cites·10 claims
- 0482US2025122184A1Oxadiazole transient receptor potential channel inhibitorsGENENTECH INC·Filed 2024·Application pending·0 cites
- 0579US12338256B2Aza-tetracyclic oxazepine compounds and uses thereofGENENTECH INC·Filed 2024·Granted Jun 24, 2025·0 cites·28 claims
- 0677US12202824B2Oxadiazole transient receptor potential channel inhibitorsGENENTECH INC·Filed 2022·Granted Jan 21, 2025·0 cites·17 claims
- 0776US12459957B2Therapeutic compounds and methodsGENENTECH INC·Filed 2024·Granted Nov 4, 2025·0 cites·20 claims
- 0875US9249158B2Cytomegalovirus inhibitor compoundsFADER LEE·Filed 2013·Granted Feb 2, 2016·3 cites·23 claims
- 0973US12428419B2Therapeutic compoundsGENENTECH INC·Filed 2024·Granted Sep 30, 2025·0 cites·14 claims
- 1072US2024025919A1Aza-tetracyclic oxazepine compounds and uses thereofGENENTECH INC·Filed 2023·Application pending·0 cites
- 1168US11655245B2Oxadiazole transient receptor potential channel inhibitorsGENENTECH INC·Filed 2020·Granted May 23, 2023·0 cites·48 claims
- 1266US11993599B2Therapeutic compoundsGENENTECH INC·Filed 2022·Granted May 28, 2024·0 cites·29 claims
- 1359US2023242506A1Heterobifunctional molecules as tead inhibitorsGENENTECHT INC·Filed 2022·Application pending·0 cites
- 1456US10647731B2Thiazolopyrimidinones and methods of use thereofGENENTECH INC·Filed 2018·Granted May 12, 2020·0 cites·70 claims
- 1552US10913742B2Oxadiazolones as transient receptor potential channel inhibitorsGENENTECH INC·Filed 2019·Granted Feb 9, 2021·0 cites·13 claims
- 1648US10711004B2Oxadiazole transient receptor potential channel inhibitorsGENENTECH INC·Filed 2019·Granted Jul 14, 2020·0 cites·23 claims
- 1744US9988400B2Thiazolopyrimidinones and methods of use thereofGENENTECH INC·Filed 2016·Granted Jun 5, 2018·0 cites·70 claims
- 1843US10280165B2Pyridopyrimidinones and methods of use thereofGENENTECH INC·Filed 2017·Granted May 7, 2019·0 cites·28 claims
- 1935US9505775B2Inhibitors of cytomegalovirusTHIBEAULT CARL·Filed 2013·Granted Nov 29, 2016·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Elisia Villemure files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →